Program Related Investment
BioROSA Technologies
Today, autism diagnosis is achieved through time-consuming and non-scalable behavioral evaluations. BioROSA seeks to transform diagnosis from behavior to biology and to detect Autism Spectrum Disorder (ASD) before behavioral onset by developing a rapid proprietary, blood-based, metabolomics and machine learning platform. This will improve patient prognosis, enable earlier intervention, support clinical trials, and reduce healthcare costs through a predictive medicine model of care.
